Merck Acquires Cell Culture Media Specialist Biochrom AG
Acquisition rounds out Merck Millipore’s portfolio of media and buffers used in biopharmaceutical production
Merck announced that it has entered into definitive agreements to acquire Biochrom AG located in Berlin, Germany. The company, with approximately 60 employees and sales of approximately € 13 million in 2011, specializes in the production and marketing of cell-culture media and buffer solutions. The parties agreed not to disclose the purchase price. The acquisition is subject to customary closing conditions such as the approval of the respective antitrust authority. Closing of the transaction is expected in the fourth quarter of 2012.
The acquisition will strengthen Merck Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for pharmaceutical and biopharmaceutical manufacturers. Biochrom’s cell-culture media products are highly complementary and innovative, adding liquid cell-culture media and buffers including serum-free products and disposable packaging solutions to the existing portfolio.
“With Biochrom we have a great opportunity to deliver an expanded portfolio of cell- culture media products to our global customers and address a growing demand for ready-to-use liquid solutions that drive safety and efficiency in the development and manufacture of clinical and commercial drug materials,” said Robert Yates, head of the Merck Millipore division.
Dr. Bernd Frenzel, CEO of Biochrom AG, said: “Merck Millipore is the ideal partner for Biochrom. With Merck Millipore we will be able to leverage their industry relationships and global footprint to reach more customers and offer a more comprehensive portfolio of media and buffers”.
It is planned to maintain Biochrom’s operations in Berlin. Biochrom’s activities will be part of Merck Millipore’s Process Solutions business unit.
Other news from the department business & finance
These products might interest you
CHOventure Growth Medium by Capricorn Scientific
High-Yield Protein Production with CHO Cells for Biopharmaceutical Applications
Optimized for High-Density Cultures and Enhanced Protein Yields in CHO Cell Bioprocessing
HEK Media by Sartorius
Serum-free cell culture media for HEK cells
Optimised for HEK293 cells and viral vector production, ISO 9001 certified
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
